Hallucinations and delusions from psychosis are not uncommon for people living with Parkinson’s disease (PD). According to the Parkinson’s Foundation, between 20-40% of people living with PD report hallucinations with the likelihood increasing as someone living with PD ages. The only FDA-approved medication for hallucinations in Parkinson disease is pimavanserin (commonly sold…
Lewy body dementia is the second-most common form of neurodegenerative dementia in the U.S. behind Alzheimer’s disease. To help combat this growing health issue, which affects over 1 million individuals in the U.S., the Harry T. Mangurian Jr. Foundation supports the Collaboration for Pilot Studies in Lewy Body Dementia, an…
The prevalence of Parkinson disease is increasing more rapidly than other neurological disorders, and is estimated to affect nearly 1 million Americans and more than 6 million people worldwide. A new review in the Journal of the Medical Association (JAMA) co-authored by Melissa Armstrong, M.D., MSc, director of the Mangurian…
